Levetiracetam for Persons at Risk for Alzheimer's Disease

NCT07477431 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hippocampal Hyperactivation
Prodromal Alzheimer Disease

Interventions

DRUG: Levetiracetam (LEV)
OTHER: Placebo

Sponsor

Sunnybrook Health Sciences Centre

Collaborators

[object Object]
[object Object]